R. Morty (Giessen, Germany), K. Borensztajn (Paris, France), A. Millar (Bristol, United Kingdom), A. Gazdhar (Bern, Switzerland)
LATE-BREAKING ABSTRACT: Age-related PINK1 deficiency promotes mitochondria dysfuntion, epithelial injury and fibrosis in the lung
M. Bueno, Y. C. lai, Y. Romero, J. Brands, C. StCroix, C. Corey, J. Herazo-Maya, J. Sembrant, S. Duncan, J. Pelewski, M. Rojas, S. Shiva, C. Chu, A. Mora (Pittsburgh, New Haven, United States Of America; Mexico DC, Mexico)
|  |
LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES
F. Uhl, S. Vierkotten, G. Burgstaller, M. Lindner, O. Eickelberg, S. Meiners, M. Königshoff (Munich, Gauting, Germany)
| |
LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
P. Geraghty, E. Eden, M. Pillai, M. Campos, N. McElvaney, R. Foronjy (New York, Miami, United States Of America; Dublin, Ireland)
| |
LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
R. Guillamat-Prats, F. Puig, R. Herrero, A. Serrano-Mollar, M. Camprubí-Rimblas, L. Chimenti, J. Tijero, M. N. Gomez, L. Blanch, A. Artigas (Sabadell, Barcelona, Spain)
| |
LATE-BREAKING ABSTRACT: Erythropoietin (EPO) inhibits the immunohistochemical expression of Tumor Necrosis Factor-a (TNF-a) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
D. Tsavlis, A. Tzoumaka, A. Tektonidou, A. Papadopoulou, E. Spandou (Thessaloniki, Greece)
|  |
LATE-BREAKING ABSTRACT: Olodaterol inhibits pro-fibrotic mechanisms in primary human lung fibroblasts
F. Herrmann, L. Wollin, E. Wex (Biberach an der Riß, Germany)
| |
Polarization of alveolar macrophages is regulated by the immunoproteasome
S. Chen, I. Keller, O. Vosyka, A. G. Lenz, O. Eickelberg, S. Meiners, T. Stoeger (Munich, Germany)
| |
Real-time microscopy of interactions between alveolar macrophages and the alveolar epithelium in situ
K. Westphalen, J. Bhattacharya (Munich, Germany)
| |
Graphene-related nanomaterials can modulate function or cellular fate in macrophages
I. W. Park, C. S. Park, J. W. Jung, J. C. Choi, J. Y. Kim, B. W. Choi, K. S. Choi, S. Y. Kim, J. W. Shin (Seoul, Republic Of Korea)
| |
Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology
O. Bardou, C. Francois, B. Crestani, K. Borensztajn (Paris, France)
| |
Fibrocyte involvement and increased prostacyclin and VEGF in the rejection process after lung transplantation
A. Andersson Sjöland, L. Thiman, I. Skog, L. Hansson, L. Eriksson, A. K. Larsson Callerfelt, L. Bjermer, G. Westergren-Thorsson (Lund, Sweden)
| |
Low oxygen tension enhances the generation of lung progenitor cells from mouse embryonic and induced pluripotent stem cells
E. Garreta, E. Melo, D. Navajas, R. Farre (Barcelona, Spain)
| |
Effect from conditioned medium of mesenchymal stem cells and antioxidant enzymes on the processes of regeneration in the trachea
A. Temnov, V. Novoselov, A. Volkova, E. Karaduleva, A. Skifas, S. Soodaeva, I. Klimanov, A. Chucalin (Moscow, Pushino, Russian Federation)
| |
Involvement of PKCeta activation in cigarette smoke extract induced apoptosis in human lung fibroblasts (MRC-5 cell)
J. W. Park, S. Y. Kyung, S. H. Jeong (Incheon, Republic Of Korea)
| |
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
L. Tamò, A. Gazdhar, A. Feki, T. Geiser (Bern, Fribourg, Switzerland)
| |
Watching the lung work: A cell culture based 3-D microfluidic device to challenge latest pulmonary drug delivery strategies with high end microscopy
N. Hobi, B. Doshi, M. Mastrak, T. Haller, M. Gulic, M. Frick (Ulm, Germany; Innsbruck, Austria)
| |
The synthetic streptococcus pneumoniae oligosaccharide conjugate protected mice from severe pneumonia
K. Reppe, C. Anish, R. Bell, S. G. Parameswarappa, S. Govindan, C. L. Pereira, K. Dietert, L. E. Sander, A. D. Gruber, N. Suttorp, P. H. Seeberger, M. Witzenrath (Berlin, Potsdam, Germany)
| |